Private Wealth Management Group, LLC Crispr Therapeutics Ag Transaction History
Private Wealth Management Group, LLC
- $301 Billion
- Q2 2025
A detailed history of Private Wealth Management Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 10 shares of CRSP stock, worth $730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$730
Previous $341,000
42.82%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
535Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$744 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$409 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$269 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$239 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$208 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.7B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....